The main objective of this study is to define, describe, and forecast the Trazodone Hydrochloride Consumption Market based on type, major players, and region. In this report, the Trazodone Hydrochloride market has been studied in America, Europe, APAC, the Middle East & Africa, and South America. The report includes detailed information about the major factors such as drivers, opportunities, restraints, and challenges influencing the growth of the Trazodone Hydrochloride market across the globe. The report strategically analyzes market segments with respect to individual growth trends, growth prospects, and contribution to the overall market.
| Trazodone Hydrochloride |
About Trazodone Hydrochloride
Trazodone, a phenylpiperazine–triazolopyridine antidepressant, was originally discovered and developed in Italy in the 1970s by Angelini research laboratories.
Trazodone is used to treat depression and to treat the combination of symptoms of anxiety and depression. Like most antidepressants, trazodone has also been used in limited numbers of patients to treat panic disorder, obsessive-compulsive disorder, attention-deficit/hyperactivity disorder, enuresis (bed-wetting), eating disorders such as bulimia nervosa, cocaine dependency, and the depressive phase of bipolar (manic-depressive) disorder. It should be noted, however, that trazodone has not received official approval from the United States Food and Drug Administration (FDA) for these secondary uses.
Only few manufacturers can produce trazodone hydrochloride (API) in USA. Teva, the Israeli company, has a production base in the United States, dominates the market with the production market share of 92.98% in 2015
The price of trazodone hydrochloride (API) has a overall upward trend from 2011 to 2016, with a little decrease in 2012 and 2015. The average price of trazodone hydrochloride (API) is about 218 USD/Kg in 2015. The average product profit margin is about 55.82% in 2015, and it also experienced fluctuations in recent years.
Covered in this report
This report presents a comprehensive overview, market shares, and growth opportunities of Trazodone Hydrochloride (API) market by product type, application, key manufacturers and key regions.
Segmentation by product type:
Trazodone Hydrochloride (API)
Others
Segmentation by application:
Antidepression
Anxiolytic
Hypnotic
Others
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:
Teva
Angelini
Mylan
Fermion
The Piramal Group
Looking for more information on this market? Request a free sample report
Key Topics Covered:
1 Scope of the Report
2 Executive Summary
3 Global Trazodone Hydrochloride by Players
4 Trazodone Hydrochloride by Regions
5 Americas
6 APAC
7 Europe
8 Middle East & Africa
9 Market Drivers, Challenges and Trends
10 Marketing, Distributors and Customer
11 Global Trazodone Hydrochloride Market Forecast
12 Key Players Analysis
13 Research Findings and Conclusion
For more information about this report visit http://www.decisiondatabases.com/ip/28536-trazodone-hydrochloride-api-consumption-market-analysis-report
About DecisionDatabases.com:
DecisionDatabases.com is a global business research reports provider, enriching decision makers and strategists with qualitative statistics. DecisionDatabases.com is proficient in providing syndicated research report, customized research reports, company profiles and industry databases across multiple domains.
Our expert research analysts have been trained to map client’s research requirements to the correct research resource leading to a distinctive edge over its competitors. We provide intellectual, precise and meaningful data at a lightning speed.
If you are interested in more information, please contact our media team at [email protected]
Contacts
DecisionDatabases.com
Phone: 9028057900
Website: http://www.decisiondatabases.com/
